Edition:
United States

Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

0.95AUD
16 Aug 2017
Change (% chg)

-- (--)
Prev Close
$0.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,402
52-wk High
$1.33
52-wk Low
$0.72

ANR.AX

Chart for ANR.AX

About

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of... (more)

Overall

Beta: --
Market Cap(Mil.): $46.94
Shares Outstanding(Mil.): 49.41
Dividend: --
Yield (%): --

Financials

  ANR.AX Industry Sector
P/E (TTM): -- 79.21 32.38
EPS (TTM): -0.00 -- --
ROI: 0.41 3.63 14.90
ROE: 0.41 5.49 16.15

BRIEF-Anatara Lifesciences seeks trading halt

* Seeks trading halt pending announcement regarding evaluation and license option agreement Source text for Eikon: Further company coverage:

Aug 16 2017

Earnings vs. Estimates